Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-PRED vs Pred Forte Bioequivalence in Cataract Surgery
NCT00854061Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Feb 2009
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prednisolone + tobramycin in cataract, sponsored by Bausch + Lomb. Started Feb 2009; status: completed.
02
Drugs
prednisolone + tobramycin
03
Conditions
cataract
Beyond the preview
Go deeper on NCT00854061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854061.